Press and Media
The latest news and press resources
DrugBank Launches Advisory Board to Guide AI Adoption in Biopharma
DrugBank, the structured intelligence graph for biopharma, today announced the formation of its Advisory Board to provide expert, cross-disciplinary guidance as the industry navigates a critical period for AI adoption.
EvE Bio and DrugBank Partner to Bring Record-Scale Pharmome-Mapping Data to the Drug-Discovery Community
Commercial sponsorship integrates EvE Bio's growing field-defining "pharmome" map - 385,572 rigorously confirmed drug-target interactions across 159 validated targets - into DrugBank's intelligence platform.
DrugBank Announces Leadership Transition as Company Accelerates into AI-Driven Future
As DrugBank approaches our twentieth anniversary, we are excited to announce a strategic leadership transition. This move is designed to accelerate our AI-powered innovation and lead our next phase of global growth.
Drugbank Announces Partnership With ASHP
DrugBank announced their partnership with the American Society of Health-System Pharmacists (ASHP). This move will combine both organization's strengths at delivering reliable, trusted data and open the door for product development collaborations to address industry gaps.
Drugbank Closes $9 Million
Now, with $9 million CAD in seed financing led by Montréal-based Brightspark Ventures, and supported by a group of strategic investors from the precision medicine and pharma spaces, DrugBank is ready to grow its team and expand its AI capabilities.
AI Week Brings Together the World AI Community
Four days of events will feature keynotes and talks from leaders in AI and machine learning. Amii (the Alberta Machine Intelligence Institute) has announced the program for AI Week, May 24-27 in Edmonton, Canada.
Drugbank's Culture is Helping Build Critical Infrastructure for Healthcare
The Edmonton-based company's debut at 19th in the under 50 employees category closely follows its success in raising $9 million of seed funding, led by Brightspark Ventures, earlier this month.
Yeg Startup Community Awards Hosted for First Time, Recognize RWI Synthetics
An Edmonton start-up company is getting recognition for its cutting edge technology that can help in emergency situations.
DrugBank Expands Coverage To Seven New Regions, Grows Global Influence
DrugBank, the world's most complete and up-to-date pharmaceutical knowledge database, expands coverage to better serve global customers.
Edmonton Startup's Drug Database Used by Millions Worldwide
Now, with $9 million CAD in seed financing led by Montréal-based Brightspark Ventures, and supported by a group of strategic investors from the precision medicine and pharma spaces, DrugBank is ready to grow its team and expand its AI capabilities.
Accelerate Fund II Invests in Drugbank the World's Largest Pharmaceutical Knowledge Base
Accelerate Fund II is excited to announce its investment in DrugBank, an Edmonton company that has developed a comprehensive, online knowledge base of essential information on drugs and drug targets.
Announcing the Second Round of Covid-19 Grants!
On March 29th, our team announced a $500,000 pool of funds to be awarded in $10,000 - $25,000 grants to startups that are using data science, machine learning, and artificial intelligence to find solutions for the myriad challenges created by COVID-19.
Drugbank Wins $125K Startup TNT Investment Summit
DrugBank, which offers “a unique bioinformatics and cheminformatics resource that combines detailed drug data with comprehensive drug target information,” won the $125,000 Startup TNT Investment Summit pitch competition last week.
A little bit about us
DrugBank is the world's first intelligent and comprehensive drug knowledge platform. With the help of artificial intelligence, our expert team authors, verifies, and structures all of the latest biomedical information so that it can be used to its fullest potential.
A little bit more about us
DrugBank is the world's first intelligent and comprehensive drug knowledge platform. With the help of artificial intelligence, our team of medical and scientific experts gather, author, verify, and structure all of the latest biomedical information into one knowledge platform. We make this platform easy to access through DrugBank Online (our free-to-use website), data downloads, or software integrations.
Our goal is to augment human intelligence so that all medical information is used to its fullest potential, because we want to ensure that everyone in the world has access to the best possible medical outcomes.
Brand Assets
Get our brand assets kit, including logos and usage guide to help determine when and how to utilize our brand.
Download Assets
Looking For Photos?
Download team and office photos and executive team headshots.
Download Photo Pack